Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice.

Autor: Clavio M; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Clinic of Hematology, Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy., Crisà E; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Ospedale Maggiore della Carità, Novara, Italy., Miglino M; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Clinic of Hematology, Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy., Guolo F; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Clinic of Hematology, Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy., Ceccarelli M; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; SCDU Epidemiologia dei Tumori, CPO Piemonte, Turin, Italy., Salvi F; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Hematology, SS Antonio e Biagio Hospital, Alessandria, Italy., Allione B; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Division of Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Ferrero D; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Division of Hematology, University of Turin, AOU Città della Salute e della Scienza, Turin, Italy., Balleari E; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Internal Medicine, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy., Finelli C; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UO Hematology, AOU Policlinico Sant'Orsola-Malpighi, University of Bologna, Bologna, Italy., Poloni A; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology, Università Politecnica Marche, AOU Ospedali Riuniti, Ancona, Italy., Selleri C; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology and Transplant Unit, San Giovanni di Dio e Ruggi d'Aragona University Hospital, Salerno, Italy., Danise P; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology Laboratory, Umberto I Hospital, Nocera Inferiore, Italy., Cilloni D; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Turin, Italy., Di Tucci AA; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Divisione di Ematologia, Ospedale Businco, Cagliari, Italy., Cametti G; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Division of Internal Medicine, ASLTO5, Turin, Italy., Freilone R; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Servizio di Oncologia ed Ematologia, Ciriè, Italy., Fanin R; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Clinica Ematologia e Trapianto Midollo Osseo, AOU Santa Maria della Misericordia, Udine, Italy., Bigazzi C; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UOC di Ematologia, Ospedale Gen. le Prov. le C. G. Mazzoni, Ascoli Piceno, Italy., Zambello R; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology and Clinical Immunology Branch, Department of Medicine, University of Padua, Padua, Italy., Crugnola M; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology Unit and BMT Center, Azienda Ospedaliero Universitaria di Parma, Parma, Italy., Oliva EN; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology Unit, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy., Centurioni R; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; UOS di Ematologia, Ospedale di Civitanova Marche, Costamartina, Italy., Alesiani F; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Unità Operativa Semplice di Ematologia, Ospedale di San Severino, San Severino Marche, Italy., Catarini M; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Divisione di Medicina Interna, Ospedale Civile di Macerata, Macerata, Italy., Castelli A; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Division of Hematology, Ospedale degli Infermi, Biella, Italy., Abbadessa A; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Onco-Hematology, AORN S. Anna e S. Sebastiano National Hospital, Caserta, Italy., Capalbo SF; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Hematology Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Foggia, Italy., Musto P; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Regional Department of Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy., Angelucci E; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Santini V; Fondazione Italiana Sindromi Mielodisplastiche-ETS, Bologna, Italy.; MDS Unit, AOU Careggi, Dipartimento di Medicina Sperimentale e Clinica, University of Florence, Florence, Italy.

Publikováno v: Cancer [Cancer] 2021 Jun 15; Vol. 127 (12), pp. 2015-2024. Date of Electronic Publication: 2021 Mar 19.

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes.

Autor: Efficace F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Cottone F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Abel G; Division of Population Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Niscola P; Hematology Unit, Sant'Eugenio Hospital, Rome, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Bonnetain F; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.; Platform Quality of Life and Cancer, INSERM 1098, University of Franche-Comté, Besançon, France., Anota A; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.; Platform Quality of Life and Cancer, INSERM 1098, University of Franche-Comté, Besançon, France., Caocci G; Department of Medical Sciences, University of Cagliari, Cagliari, Italy., Cronin A; Division of Population Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Fianchi L; Institute of Hematology, Catholic University of the Sacred Heart, Rome, Italy., Breccia M; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy., Stauder R; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria., Platzbecker U; Department of Medicine I, University Hospital Dresden Carl Gustav Carus, Dresden, Germany., Palumbo GA; UO Ematologia, AOU Policlinico-V Emanuele, Catania, Italy., Luppi M; Department of Hematology, University of Modena, Modena, Italy., Invernizzi R; Department of Internal Medicine, University of Pavia, San Matteo IRCCS Policlinic Foundation, Pavia, Italy., Bergamaschi M; San Martino Clinical Hematology Clinic, Genova, Italy., Borin L; Department of Hematology, San Gerardo Hospital, Monza, Italy., Di Tucci AA; Hematology and Bone Marrow Transplantation Unit, Armando Businco Hospital, Cagliari, Italy., Zhang H; Department of Hematology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China., Sprangers M; Department of Medical Psychology, Academic Medical Center/University of Amsterdam, Amsterdam, the Netherlands., Vignetti M; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Mandelli F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy.

Publikováno v: Cancer [Cancer] 2018 Mar 15; Vol. 124 (6), pp. 1251-1259. Date of Electronic Publication: 2017 Dec 12.

Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy.

Autor: Efficace F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Santini V; Functional Unit of Haematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy., La Nasa G; Bone Marrow Transplantation Center, R. Binaghi Hospital, Cagliari, Italy., Cottone F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Finelli C; Department of Hematology, Policlinico S. Orsola-Malpighi, Bologna, Italy., Borin L; Department of Hematology, San Gerardo Hospital, Monza, Italy., Quaresmini G; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., Di Tucci AA; Hematology and Bone Marrow Transplantation Unit, Ospedale Oncologico di Riferimento Regionale 'Armando Businco', Cagliari, Italy., Volpe A; Hematology Division, A.O.R.N. San G. Moscati, Avellino, Italy., Cilloni D; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy., Quarta G; Division of Hematology, Ospedale A. Perrino, Brindisi, Italy., Sanpaolo G; Department of Hematology, IRCCS 'Casa Sollievo della Sofferenza' Hospital, San Giovanni Rotondo, Italy., Rivellini F; UO Medicina Interna e Onco-Ematologica P.O. 'Umberto I', Nocera Inferiore, Italy., Salvi F; Department of Hematology, A.O. Nazionale Santi Antonio e Biagio e C. Arrigo, Alessandria, Italy., Molteni A; Department of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy., Voso MT; Department of Hematology, Università Cattolica del Sacro Cuore, Rome, Italy., Alimena G; Department of Hematology, 'Sapienza' University of Rome, Rome, Italy., Fenu S; Department of Hematology, San Giovanni Hospital, Rome, Italy., Mandelli F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Angelucci E; Hematology and Bone Marrow Transplantation Unit, Ospedale Oncologico di Riferimento Regionale 'Armando Businco', Cagliari, Italy.

Publikováno v: BMJ supportive & palliative care [BMJ Support Palliat Care] 2016 Mar; Vol. 6 (1), pp. 80-8. Date of Electronic Publication: 2014 Sep 09.

Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial).

Autor: Angelucci E; Hematology and Bone Marrow Transplantation Unit, Ospedale Oncologico di Riferimento Regionale 'Armando Businco', Cagliari, Italy., Santini V, Di Tucci AA, Quaresmini G, Finelli C, Volpe A, Quarta G, Rivellini F, Sanpaolo G, Cilloni D, Salvi F, Caocci G, Molteni A, Vallisa D, Voso MT, Fenu S, Borin L, Latte G, Alimena G, Storti S, Piciocchi A, Fazi P, Vignetti M, Tura S

Publikováno v: European journal of haematology [Eur J Haematol] 2014 Jun; Vol. 92 (6), pp. 527-36. Date of Electronic Publication: 2014 Apr 10.

The evolving clinical scenario of myelodysplastic syndrome: the need for a complete and up to date upfront diagnostic assessment.

Autor: Pilo F; Hematology Unit, Ospedale Oncologico di riferimento Regionale Armando Businco Cagliari, Italy., Di Tucci AA, Dessalvi P, Caddori A, Angelucci E

Publikováno v: European journal of internal medicine [Eur J Intern Med] 2010 Dec; Vol. 21 (6), pp. 490-5. Date of Electronic Publication: 2010 Oct 12.